PURPOSE: Sphingolipids are bioactive lipids implicated in apoptosis, cell survival and proliferation. We analyzed the prognostic value of enzymes from sphingolipid metabolism in breast cancer. METHODS: Differences in expression of ceramide galactosyl transferase (UGT8), ceramide kinase (CERK), and Ganglioside GD3-Synthase (ST8SIA1) in breast cancer cells were investigated by using microarray data of 1,581 tumor samples. RESULTS: UGT8, CERK, and ST8SIA1 were associated with poor pathohistological grading (P < 0.001). High CERK expression was correlated with ErbB2 status (P = 0.006). Among ER positive breast cancers a significant worse prognosis for patients with tumors showing low ST8SIA1 and UGT8 expression was observed. In the ER negative subgroup those samples with high CERK expression displayed a worse prognosis. In a multivariate analysis only ST8SIA1 and tumor size remained significant. CONCLUSIONS: Our experiments reveal that expression of enzymes from the sphingolipid metabolism has prognostic implications in breast cancer.
PURPOSE:Sphingolipids are bioactive lipids implicated in apoptosis, cell survival and proliferation. We analyzed the prognostic value of enzymes from sphingolipid metabolism in breast cancer. METHODS: Differences in expression of ceramide galactosyl transferase (UGT8), ceramide kinase (CERK), and Ganglioside GD3-Synthase (ST8SIA1) in breast cancer cells were investigated by using microarray data of 1,581 tumor samples. RESULTS:UGT8, CERK, and ST8SIA1 were associated with poor pathohistological grading (P < 0.001). High CERK expression was correlated with ErbB2 status (P = 0.006). Among ER positive breast cancers a significant worse prognosis for patients with tumors showing low ST8SIA1 and UGT8 expression was observed. In the ER negative subgroup those samples with high CERK expression displayed a worse prognosis. In a multivariate analysis only ST8SIA1 and tumor size remained significant. CONCLUSIONS: Our experiments reveal that expression of enzymes from the sphingolipid metabolism has prognostic implications in breast cancer.
Authors: Poulami Mitra; Michael Maceyka; Shawn G Payne; Nadia Lamour; Sheldon Milstien; Charles E Chalfant; Sarah Spiegel Journal: FEBS Lett Date: 2007-01-25 Impact factor: 4.124
Authors: Valérie Gouazé; Yong-Yu Liu; Carlton S Prickett; Jing Y Yu; Armando E Giuliano; Myles C Cabot Journal: Cancer Res Date: 2005-05-01 Impact factor: 12.701
Authors: Andy J Minn; Gaorav P Gupta; David Padua; Paula Bos; Don X Nguyen; Dimitry Nuyten; Bas Kreike; Yi Zhang; Yixin Wang; Hemant Ishwaran; John A Foekens; Marc van de Vijver; Joan Massagué Journal: Proc Natl Acad Sci U S A Date: 2007-04-09 Impact factor: 11.205
Authors: Yudi Pawitan; Judith Bjöhle; Lukas Amler; Anna-Lena Borg; Suzanne Egyhazi; Per Hall; Xia Han; Lars Holmberg; Fei Huang; Sigrid Klaar; Edison T Liu; Lance Miller; Hans Nordgren; Alexander Ploner; Kerstin Sandelin; Peter M Shaw; Johanna Smeds; Lambert Skoog; Sara Wedrén; Jonas Bergh Journal: Breast Cancer Res Date: 2005-10-03 Impact factor: 6.466
Authors: Kang Liu; Juliana Idoyaga; Anna Charalambous; Shin-Ichiro Fujii; Anthony Bonito; Jose Mordoh; Rosa Wainstok; Xue-Feng Bai; Yang Liu; Ralph M Steinman Journal: J Exp Med Date: 2005-12-05 Impact factor: 14.307
Authors: Benjamin Newcomb; Cosima Rhein; Izolda Mileva; Rasheed Ahmad; Christopher J Clarke; Justin Snider; Lina M Obeid; Yusuf A Hannun Journal: J Lipid Res Date: 2018-05-03 Impact factor: 5.922
Authors: Aurélie Cazet; Sylvain Julien; Marie Bobowski; Joy Burchell; Philippe Delannoy Journal: Breast Cancer Res Date: 2010-06-08 Impact factor: 6.466